Investor Relations

Company Overview

Assembly Biosciences, Inc. (Nasdaq: ASMB) is a public biotechnology company advancing a new class of oral biologic drugs for addressing the gut microbiome and novel approaches to discovering drugs for the treatment of hepatitis B virus (HBV) infection.

Stock Quote

NASDAQ: ASMB
32.33
+ 1.84 (+6.04%)
1:22 PM ET on Sep 21, 2017
Delayed at least 20 minutes.

Stock Chart

Press Releases

Events & Presentations

June 07, 2017 at 10:00 AM ET

Investor Contact

investors@assemblybio.com